Literature DB >> 33331308

[Clinical and laboratory characteristics of rheumatoid arthritis with positive antinuclear antibody].

J F Zhang, X L Ye, M Duan, X L Zhou, Z Q Yao, J X Zhao.   

Abstract

OBJECTIVE: To analyse the clinical and laboratory characteristics of antinuclear antibody (ANA) positive rheumatoid arthritis (RA) patients.
METHODS: The clinical and laboratory data of 428 RA cases from Department of of Rheumatology and Immunology Peking University Third Hospital from Jan 2013 to Dec 2018 were collected and used to analyse characters between ANA positive group and ANA negative group. T test was used for the quantitative data in accordance with normal distribution. Wilcoxon rank sum test was used for the quantitative data of non normal distribution. The qualitative data were analyzed by chi square test. But while 1≤theoretical frequency < 5, chi square test of corrected four grid table was used. And Fisher exact probability method was used when theoretical frequency < 1.
RESULTS: The number of ANA positive group was 231 (54%). The female rate was obviously higher in ANA positive group (82.7% vs. 63.5%, χ2=20.355, P < 0.01). The rate of metatarsophalangeal joints (MTPJs) involvement was lower in ANA positive group (22.1%) than in ANA negative group (33.0) (χ2=6.414, P < 0.05). The incidence of secondary Sjögren's syndrome (sSS) was much higher in ANA positive group(19.5% vs. 4.1%, χ2=23.300, P < 0.01). The positivity of rheumatoid factor (RF), as well as the positivity of anti-cyclic citrullinated peptide(CCP) antibody was much higher in ANA positive group (77.1% vs. 53.8%, χ2=25.743, P < 0.01, 74.9% vs. 59.4%, χ2=11.694, P < 0.01, respectively). The levels of immunoglobulin G (IgG) and immunoglobulin M (IgM) of ANA positive group were higher [(15.1±5.1) g/L vs. (13.8±5.3) g/L, t=2.359, P < 0.05, 1.25 (0.92) g/L vs. 1.05 (0.65) g/L, Z=-3.449, P < 0.01, respectively]. But the levels of hemoglobin (Hb) and platelet (PLT) was lower in ANA positive group[(109.64±17.98) vs. (114.47±18.48) g/L, t=-2.734, P < 0.01; (266.4×109±104.6×109) vs. (295.9×109±100.1×109) /L, t=-2.970, P < 0.01, respectively].
CONCLUSION: The incidence of sSS was obviously higher in ANA positive group than in ANA negative group. Serum IgG of ANA positive group was higher, but Hb and PLT were lower.

Entities:  

Keywords:  Rheumatoid arthritis, antinuclear antibody; Rheumatoid factor, anti-cyclic citrullinated peptide antibody; Secondary Sjögren's syndrome

Mesh:

Substances:

Year:  2020        PMID: 33331308      PMCID: PMC7745268     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  14 in total

1.  Prevalence of antinuclear autoantibodies in the serum of normal blood dornors.

Authors:  Solange Assuncion Villagra Fernandez; Alice Zoghbi Coelho Lobo; Zilda Najjar Prado de Oliveira; Ligia Maria Ichimura Fukumori; Alexandre Marques P rigo; Evandro A Rivitti
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  2004-01-28

2.  Rheumatoid arthritis in the Women's Health Initiative: methods and baseline evaluation.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Larry W Moreland
Journal:  Am J Epidemiol       Date:  2014-02-24       Impact factor: 4.897

Review 3.  Inflammatory and immune responses in the arterial media.

Authors:  George Tellides; Jordan S Pober
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

4.  Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008-2015: a cross-sectional study involving 10,814 subjects.

Authors:  Eddie Racoubian; Reem M Zubaid; Marwa A Shareef; Wassim Y Almawi
Journal:  Rheumatol Int       Date:  2016-07-13       Impact factor: 2.631

5.  Secondary Sjögren's syndrome and disease activity of rheumatoid arthritis.

Authors:  Daniel C Antero; André G M Parra; Fernando H Miyazaki; Marcelo Gehlen; Thelma L Skare
Journal:  Rev Assoc Med Bras (1992)       Date:  2011 May-Jun       Impact factor: 1.209

Review 6.  Prognostic value of antinuclear antibodies in juvenile idiopathic arthritis and anterior uveitis. Results from a systematic literature review.

Authors:  Raquel Campanilho-Marques; Mónica Bogas; Filipa Ramos; Maria José Santos; João Eurico Fonseca
Journal:  Acta Reumatol Port       Date:  2014 Apr-Jun       Impact factor: 1.290

7.  Studies of antinuclear antibodies in rheumatoid arthritis.

Authors:  I Garcia-de la Torre; L Miranda-Mendez
Journal:  J Rheumatol       Date:  1982 Jul-Aug       Impact factor: 4.666

8.  Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen.

Authors:  C T Aitcheson; C Peebles; F Joslin; E M Tan
Journal:  Arthritis Rheum       Date:  1980-05

9.  Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.

Authors:  Naoichiro Yukawa; Takao Fujii; Seiko Kondo-Ishikawa; Hajime Yoshifuji; Daisuke Kawabata; Takaki Nojima; Koichiro Ohmura; Takashi Usui; Tsuneyo Mimori
Journal:  Arthritis Res Ther       Date:  2011-12-22       Impact factor: 5.156

10.  Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.

Authors:  Boris Hügle; Claas Hinze; Elke Lainka; Nadine Fischer; Johannes-Peter Haas
Journal:  Pediatr Rheumatol Online J       Date:  2014-07-16       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.